A team of scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has identified a promising new drug target for acute myeloid leukemia (AML), a deadly blood cancer with a five-year survival rate of just 30%, according to the National Cancer Institute. Their study, published in Cell Stem Cell  in February, highlights the crucial role of a protein called paraspeckle component 1 (PSPC1) in the progression of AML.

World-first research from the University of South Australia shows that autistic students are still struggling at school, despite efforts to improve services and supports.

Recent research from the University of Michigan reveals that simple awareness on the part of the care team can help protect the breastfeeding relationship for patients in the ICU.

The new study led by researchers from the Texas A&M University School of Public Health found that participation in three types of virtual diabetes self-management interventions in both rural and urban locations resulted in better hemoglobin A1c markers over a six-month study period.